Table of Contents
-Session 1- Performance Characteristics and Limitations of Currently Available Genotypic and Phenotypic Assays
Session 1 Objectives
Session 1 Objectives (cont.)
-Session 2- Evaluation of Relationships between Genotype, Phenotype and Treatment Outcome
Session 2 Objectives
Session 2 Objectives (cont.)
-Session 3- Practical Considerations for the Use of Resistance Testing in Antiretroviral Drug Development and Use
Session 3 Objectives
-Session 4- Potential Roles of Resistance Testing in Drug Development
Session 4 Objectives
Session 4 Objectives (cont.)
|
Author: CDER User
|